hal2kilo
Lifer
- Feb 24, 2009
- 25,633
- 11,983
- 136
Because he doesn't want himself or others having their POE (purity of essence) adjusted.Are we running out of vaccine? Why do we need to focus on only one group?
Because he doesn't want himself or others having their POE (purity of essence) adjusted.Are we running out of vaccine? Why do we need to focus on only one group?
"You would have a point if getting the booster lowers a person chance of getting COVID at all(The type of protection that the Measles vaccine gives a person), but the Booster doesn't do that either."
My original point that the COVID vaccine doesn't provide the same level of protection(As you say the pathogens are different) that the Measles vaccine provides because which would be a good reason to push more people to get vaccinated/boosted. The COVID vaccine works more like a pre-infection treatment to lower the severity of your infection. While the Measles vaccine can prevent you from getting sick at all and becoming infectious. If there was a COVID vaccine available that is shown to significantly lower the chance of someone getting COVID and being infectious that would be a good reason to try and encourage everyone to get a updated booster. Even those in low risk groups. Until we have that type of vaccine we should focus on people in the highest risk groups getting vaccinated to lower the severity of their infection.
Are we running out of vaccine? Why do we need to focus on only one group?
It's becoming clearer that you really don't know what it is you're attempting to talk about here.
"Why can't vaccine for pathogen X act just like the vaccine for pathogen Y?" isn't really a great hill to die on. And now we're wandering into the whole "vaccine definition argument" territory.
I'm done here. Best of luck.
You mean this guy? Who compared the COVID response to Nazi Germany?The potential benefits need to outweigh the potential harms, would you agree? https://static01.nyt.com/newsgraphics/documenttools/24b944c1a77fbed7/209038df-full.pdf
The decrease in the chance of developing severe COVID-19 means that the potential for absolute benefit from vaccination has simultaneously decreased. Even rare vaccination-related harms, both known and unknown, now have a higher chance of outweighing potential benefits in non-high-risk populations. Some harm-benefit analyses suggested net harm of ongoing vaccination of low-risk populations. Post-vaccination myocarditis is a known risk of the Novavax vaccine, and there have been unfavorable imbalances in rates of neurological, cardiac, and thrombotic adverse events among vaccine recipients reported by the Applicant. These adverse events could represent significant risks for which studies to date have been underpowered to confidently attribute to vaccination. Although the FDA monitors the safety of all vaccines through post-market surveillance, it is important to acknowledge times at which the potential for benefit from vaccination among non-high-risk individuals is small and poorly defined.
They'll say COVID is fake just like they have been the last five years when it has happened.What will gun toting vengeful Trumpists do when they discover their so called God killed a beloved family member?
You mean this guy? Who compared the COVID response to Nazi Germany?
How Democracy Ends
COVID19 policy shows a (potential) path to the end of Americawww.drvinayprasad.com
Pretty much what I envisioned, one form of rationalization or another. Thumbs up!They'll say COVID is fake just like they have been the last five years when it has happened.
I'm at the point where I am miffed when TV news chants the Trump administration's position on an issue. My truth meter needle gets pinned to Monstrous Lie.This is what happens when you put an anti-vaccine crank in charge of HHS who appoints his crank buddies. And it was egged on by bullshit media headlines for years that launder anti-vaccine propaganda as "skepticism". A lot of journalists are failing the "don't print lies" test, and fail to understand that you don't have to give equal weight to the crank and the entire body of science.
That’s a lot of words and no risk likelihoods numbers.The potential benefits need to outweigh the potential harms, would you agree? https://static01.nyt.com/newsgraphics/documenttools/24b944c1a77fbed7/209038df-full.pdf
The decrease in the chance of developing severe COVID-19 means that the potential for absolute benefit from vaccination has simultaneously decreased. Even rare vaccination-related harms, both known and unknown, now have a higher chance of outweighing potential benefits in non-high-risk populations. Some harm-benefit analyses suggested net harm of ongoing vaccination of low-risk populations. Post-vaccination myocarditis is a known risk of the Novavax vaccine, and there have been unfavorable imbalances in rates of neurological, cardiac, and thrombotic adverse events among vaccine recipients reported by the Applicant. These adverse events could represent significant risks for which studies to date have been underpowered to confidently attribute to vaccination. Although the FDA monitors the safety of all vaccines through post-market surveillance, it is important to acknowledge times at which the potential for benefit from vaccination among non-high-risk individuals is small and poorly defined.
That’s a lot of words and no risk likelihoods numbers.
The risk of long covid symptoms is single to double digit percentages of people who have caught COVID while the risk of myocarditis was about 6-7/100,000 for vaccine recipients. Orders of magnitude lower. And the vaccine reduces your chance of long COVID by double digit percentages.
You would have to measure it against the population in question which is the low risk population for COVID which is those under age 50 with no known health risk's. That population has a very low risk of severe COVID and getting myocarditis from a COVID infections. So low the risk of getting COVID and myocarditisFor the record, on myocarditis risks ... covid vaccinations have NEVER been linked to an incidence rate higher than that of the general population. Myocarditis can be caused by any infection, is almost always mild, and is most often found in adolescent males.
Additionally, the myocarditis rate in actual covid patients is something like 10x higher than gen pop.
TLDR;
Myocarditis risk chances
Vaccinated < Gen pop < Actual covid infection
Tell me, which would you pick?
You would have to measure it against the population in question which is the low risk population for COVID which is those under age 50 with no known health risk's. That population has a very low risk of severe COVID and getting myocarditis from a COVID infections. So low the risk of getting COVID and myocarditis
Wouldn't you need to break out the population into the risk group we are talking about?